VASCULOSTATIN

pharmaceutical preparations, namely, angiogenesis inhibitor protein compositions for the treatment of diseases and biological processes that are mediated by angiogenesis, namely, cancer, macular degeneration, diabetic retinopathy, Crohn's disease, psoriasis and arthritis